European Medicines Agency Executive Director Claims that Smarter Regulation Could Control Rising Drug Prices Life Science Investing
OncoMed Pharmaceuticals Presents New Data at the San Antonio Breast Cancer Symposium Life Science Investing
Progenics Pharmaceuticals Has Completed Enrollment in Clinical Trial for Azedra Life Science Investing
XOMA Licences Global Development and Commercialization Rights to XMetA Program Life Science Investing
Eisai and Arena Pharmaceuticals Announce the FDA's Acceptance of a New Drug Application for Lorcaserin Life Science Investing
